Results 81 to 90 of about 517,815 (166)

Ethical Considerations in Islet Xenotransplantation

open access: yesXenotransplantation, Volume 33, Issue 4, July/August 2026.
ABSTRACT For the management of type 1 diabetes, islet xenotransplantation has emerged as a potential alternative to lifelong insulin therapy or islet allotransplantation. However, this progress raises significant ethical questions that warrant further exploration.
Daniel J. Hurst   +6 more
wiley   +1 more source

Genome-wide inactivation of porcine endogenous retroviruses (PERVs)

open access: yes, 2017
The shortage of organs for transplantation is a major barrier to the treatment of organ failure. While porcine organs are considered promising, their use has been checked by concerns about transmission of porcine endogenous retroviruses (PERVs) to humans.
Niu, D.   +13 more
core   +1 more source

Intracellularly expressed single-domain antibody against p15 matrix protein prevents the production of porcine retroviruses [PDF]

open access: yes, 2003
The presence of porcine endogenous retroviruses presents a potential risk of transmission of infectious diseases (xenozoonosis) if tissues and organs from genetically modified pigs are to be used in xenotransplantation.
Ton de Wit   +13 more
core   +2 more sources

Detection of a gammaretrovirus, XMRV, in the human population: Open questions and implications for xenotransplantation

open access: yesRetrovirology, 2010
XMRV (xenotropic murine leukaemia virus-related virus) is a gammaretrovirus that has been detected in human patients with prostate carcinoma, chronic fatigue syndrome (CFS) and also in a small percentage of clinically healthy individuals.
Denner Joachim
doaj   +1 more source

Genomic insights into evolutionary journey of the porcine endogenous retroviruses [PDF]

open access: yes, 2018
Abstract Background Xenotransplantation may overcome significant shortage of human allotransplant. Porcine organs are considered favorable for xenotransplantation duo to similar size and function to human organ.
Chen, Yicong   +3 more
openaire   +1 more source

Xenotransplantation Literature Update: January–June 2026

open access: yesXenotransplantation, Volume 33, Issue 4, July/August 2026.
ABSTRACT In the first half of 2026, xenotransplantation advanced through refinement rather than dramatic new clinical milestones. Clinical studies described graft physiology, immune infiltration, complement activation, coagulation incompatibility, and early function in living recipients, decedent models, and clinical islet xenotransplantation ...
Kasra Shirini   +3 more
wiley   +1 more source

A Comprehensive Strategy for Screening for Xenotransplantation-Relevant Viruses in a Second Isolated Population of Göttingen Minipigs

open access: yesViruses, 2019
Xenotransplantation using pig tissues and organs is under development in order to alleviate the increasing shortage of human transplants. Since xenotransplantation may be associated with the transmission of porcine microorganisms to the human recipient ...
Luise Krüger   +6 more
doaj   +1 more source

Porcine kidney xenotransplantation: From primate models to clinical reality

open access: yesAnimal Models and Experimental Medicine, Volume 9, Issue 6, Page 1142-1166, June 2026.
In the face of a critical shortage of human donor kidneys for end‐stage renal disease patients, porcine kidney xenotransplantation has emerged as a viable solution. This field has navigated major hurdles, including immune rejection, physiological incompatibilities, potential biomechanical differences and the risk of cross‐species infection. To overcome
Zihang Guo   +3 more
wiley   +1 more source

Xenotransplantation: where do we stand in 2016?

open access: yesSwiss Medical Weekly, 2017
Worldwide, there is a constant rise in the number of patients with end-stage organ failure in critical need for transplants, but the number of organs/cells available from deceased or living human donors is limited.
Gisella L. Yung Puga   +4 more
doaj   +1 more source

Artificial Cells for the Development of Cell Therapy

open access: yesCell Transplantation, 2008
In developing cell therapy, normal human cells are ideal as a cell source, but considering the serious lack of donor organs, it is unlikely to obtain a large enough amount of human cells.
Naoya Kobayashi
doaj   +1 more source

Home - About - Disclaimer - Privacy